Invention Application
US20120322804A1 N-LINKED HETEROCYCLIC RECEPTOR AGONISTS FOR THE TREATMENT OF DIABETES AND METABOLIC DISORDERS
有权
用于治疗糖尿病和代谢障碍的N-连锁异位受体激动剂
- Patent Title: N-LINKED HETEROCYCLIC RECEPTOR AGONISTS FOR THE TREATMENT OF DIABETES AND METABOLIC DISORDERS
- Patent Title (中): 用于治疗糖尿病和代谢障碍的N-连锁异位受体激动剂
-
Application No.: US13463617Application Date: 2012-05-03
-
Publication No.: US20120322804A1Publication Date: 2012-12-20
- Inventor: Jingyuan Ma , Christopher J. Rabbat , Jiangao Song , Xin Chen , Imad Nashashibi , Zuchun Zhao , Aaron Novack , Dong Fang Shi , Peng Cheng , Yan Zhu , Alison Murphy
- Applicant: Jingyuan Ma , Christopher J. Rabbat , Jiangao Song , Xin Chen , Imad Nashashibi , Zuchun Zhao , Aaron Novack , Dong Fang Shi , Peng Cheng , Yan Zhu , Alison Murphy
- Assignee: Metabolex Inc.
- Current Assignee: Metabolex Inc.
- Main IPC: A61K31/454
- IPC: A61K31/454 ; C07D401/14 ; A61K31/506 ; C07D413/14 ; A61K31/4545 ; C12N5/0783 ; A61K31/5377 ; A61K31/4709 ; C07D451/02 ; A61K31/46 ; A61P3/10 ; C12N5/071 ; C07D401/04 ; C07D417/14
Abstract:
Compounds and methods are provided for the treatment of, inter alia, Type II diabetes and other diseases associated with poor glycemic control.
Public/Granted literature
- US08846675B2 N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders Public/Granted day:2014-09-30
Information query
IPC分类:
